SCICLONE PHARMACEUTICALS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-04-24: Reporting owner Blobel Friedhelm; Form 4; Security Non-Qualified Stock (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-05-12: Reporting owner Blobel Friedhelm; Form 4; Security Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-04-24 | Blobel Friedhelm Director, Officer (President & CEO) | 4 | Non-Qualified Stock (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 719,360 owned after | $9.07 | 2015-04-24 | |
| 2011-05-12 | Blobel Friedhelm Director, Officer (President & CEO) | 4 | Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $5.13 | 2011-05-16 |